Maria  Rivas net worth and biography

Maria Rivas Biography and Net Worth

Director of Cooper Companies

Dr. Rivas currently serves as Global Chief Medical Affairs Officer and Head, Evidence Generation for Pfizer, Inc. (NYSE: PFE). Until September 2022, she served as Chief Medical Officer and Senior Vice President for the healthcare business of Merck KGaA, Darmstadt, Germany (which operates as EMD Serono in the US and Canada) where she led the Global Pharmacovigilance, Medical Affairs and Evidence and Value Development (HEOR) teams in over 90 countries. Dr. Rivas has extensive experience in driving growth and commercialization strategies, global operations, digital transformation, and crisis and risk management in highly regulated industries.

Prior to that, Dr. Rivas served as Senior Vice President of Global Medical Affairs at Merck & Co (MSD), as Vice President of Global Medical Affairs at Abbvie, as Vice President of Oncology, General Medicine and Diagnostic Imaging Medical Affairs at Bayer Healthcare, and in various roles at Eli Lilly including Head of US Women’s Health Medical Affairs. Before joining Eli Lilly, Dr. Rivas was in private practice as an endocrinologist in Puerto Rico. 

Dr. Rivas obtained a BA in Biochemistry from Brandeis University, Waltham, MA and an MD from Columbia University’s Vagelos College of Physicians and Surgeons, New York, NY. She completed a residency in Internal Medicine and a fellowship in Endocrinology at NY-Presbyterian Hospital, New York, NY. Dr. Rivas is board certified in Endocrinology, Diabetes and Metabolism. 

Dr. Rivas served as a director for Medidata (NASDAQ: MDSO), a public, mid-cap health technology company, until its successful merger with Dassault Systèmes. She served as a member of the audit and compensation committees for Medidata.

What is Maria Rivas' net worth?

The estimated net worth of Maria Rivas is at least $934.06 thousand as of December 18th, 2025. Dr. Rivas owns 11,141 shares of Cooper Companies stock worth more than $934,061 as of December 23rd. This net worth estimate does not reflect any other investments that Dr. Rivas may own. Learn More about Maria Rivas' net worth.

How do I contact Maria Rivas?

The corporate mailing address for Dr. Rivas and other Cooper Companies executives is 6101 Bollinger Canyon Road Suite 500, San Ramon CA, 94583. Cooper Companies can also be reached via phone at (925) 460-3600 and via email at [email protected]. Learn More on Maria Rivas' contact information.

Has Maria Rivas been buying or selling shares of Cooper Companies?

Within the last three months, Maria Rivas has bought $82,130.00 in shares of Cooper Companies stock. Most recently, on Thursday, December 18th, Maria Rivas bought 1,000 shares of Cooper Companies stock. The stock was acquired at an average cost of $82.13 per share, with a total value of $82,130.00. Following the completion of the transaction, the director now directly owns 11,141 shares of the company's stock, valued at $915,010.33. Learn More on Maria Rivas' trading history.

Who are Cooper Companies' active insiders?

Cooper Companies' insider roster includes Brian Andrews (CFO), Robert Auerbach (CEO), Lawrence Kurzius (Director), Jody Lindell (Director), Daniel McBride (COO), Gary Petersmeyer (Director), Agostino Ricupati (SVP), Maria Rivas (Director), Holly Sheffield (EVP), Gerard Warner, III (COO), Robert Weiss (Director), and Albert White, III (CEO). Learn More on Cooper Companies' active insiders.

Are insiders buying or selling shares of Cooper Companies?

In the last year, Cooper Companies insiders bought shares 9 times. They purchased a total of 32,205 shares worth more than $2,370,798.00. The most recent insider tranaction occured on December, 18th when Director Maria Rivas bought 1,000 shares worth more than $82,130.00. Insiders at Cooper Companies own 2.0% of the company. Learn More about insider trades at Cooper Companies.

Information on this page was last updated on 12/18/2025.

Maria Rivas Insider Trading History at Cooper Companies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/18/2025Buy1,000$82.13$82,130.0011,141View SEC Filing Icon  
See Full Table

Maria Rivas Buying and Selling Activity at Cooper Companies

This chart shows Maria Rivas's buying and selling at Cooper Companies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cooper Companies Company Overview

Cooper Companies logo
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Read More

Today's Range

Now: $82.70
Low: $82.88
High: $83.61

50 Day Range

MA: $74.99
Low: $68.76
High: $83.84

2 Week Range

Now: $82.70
Low: $61.78
High: $100.24

Volume

404,482 shs

Average Volume

2,467,746 shs

Market Capitalization

$16.21 billion

P/E Ratio

44.02

Dividend Yield

N/A

Beta

1.05